Keyphrases
Access to Care
100%
Public Institutions
100%
Medicine Pricing
100%
Pharmaceutical R&D
100%
Quality of Care
50%
Economic Impact
50%
Development Time
50%
Expert Opinion
50%
Government Authorities
50%
Pharmaceutical Industry
50%
Societal Impacts
50%
Cost of Capital
50%
Drug Development
50%
Area Cover
50%
Taking Risks
50%
Potential Change
50%
Cost Categories
50%
Changing Position
50%
Failure Cost
50%
Medicines Development
50%
Investments in R&D
50%
High-quality Care
50%
Political Impact
50%
Potential Development
50%
Public Investment
50%
Affordability of Medicines
50%
Social Sciences
Research and Development
100%
Drugs
100%
Opportunity Cost
100%
Pricing
40%
Political Economics
20%
Development Potential
20%
Pharmaceutical Industry
20%
Societal Impact
20%
Public Investment
20%
Cost of Capital
20%
Risk Behavior
20%
Economics, Econometrics and Finance
Affordability
100%
Opportunity Cost
100%
Pricing
66%
Capital Requirements
33%
Cost of Capital
33%
Societal Impact
33%
Cost Categories
33%
Public Investment
33%
Pharmaceutical Industry
33%